By understanding whole-plant extractions better, businesses will be able to better plan for long-term profitability and sustainability.
David L. Nathan, MD, DFAPA, President, Board of Directors, Doctors for Cannabis Regulations (DFCR), discusses how the DFCR was formed, the efforts they have been making in the cannabis field, and plans for the future of the organization.
In honor of National Women’s Month, Josh Crossney highlights some of the amazing women that will be speaking at the first Cannabis Science Conference East show.
Ricki Lake discusses returning to Baltimore to speak at CSC East and her award-winning documentary, Weed the People.
Here we take a closer look at Australia’s medical cannabis program, the laws surrounding it, and speak to Australian pharmacist Paul Mavor.
The Latest Medical Cannabis Research: Dr. Ethan Russo Discusses Neurological Research, Dosing, and More
Dr. Ethan Russo, Director of Research and Development for the International Cannabis and Cannabinoids Institute (ICCI), recently spoke with us about some of his recent research efforts, cannabis dosing, and his continued push to change the stigma against cannabis as a medicine.
Paul Mavor, an Australian and UK licensed pharmacist and the CEO and Founder of Health House International, recently spoke to us about Australia’s medical cannabis program, the testing and regulations in place, and the future outlook for cannabis in his country.
Ohio kicked off their medical cannabis sales on Wednesday, January 16, 2019.
The New Zealand government passed a law on December 11, 2018, that will establish a regulated medical cannabis scheme within one year.
South Korea has become the first country in East Asia to legalize medical cannabis.